共 9 条
[1]
Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell‐mediated anti‐tumour immunity in a murine mammary breast cancer model[J] . H.Hong,Y.Gu,H.Zhang,A. K.Simon,X.Chen,C.Wu,X.‐N.Xu,S.Jiang.  Clinical & Experimental Immunology . 2009 (1)
[2]
The biology of NKT cells. Bendelac A,Savage PB,Teyton L. Annual Review of Immunology . 2007
[3]
Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J] . Mark A.A. Claassen,Robert J. de Knegt,Hugo W. Tilanus,Harry L.A. Janssen,André Boonstra.  Journal of Hepatology . 2009 (3)
[4]
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. Ghiringhelli F,Menard C,Terme M,et al. Journal of Experimental Medicine, The . 2005
[5]
Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage[J] . Heda Kvakan,Markus Kleinewietfeld,Fatimunnisa Qadri,Joon-Keun Park,Robert Fischer,Ines Schwarz,Hans-Peter Rahn,Ralph Plehm,Maren Wellner,Saban Elitok,Petra Gratze,Ralf Dechend,Friedrich C. Luft,Dominik N. Muller.  Circulation . 2009 (22)
[7]
Management of hepatitis B in China. Lu FM,Zhuang H. Chinese Medical Journal . 2009
[8]
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss,L.,Bergmann,C.,Szczepanski,M. Clinical Cancer Research . 2007